Telum Therapeutics
Telum Therapeutics42About
What does Telum Therapeutics do?
Telum Therapeutics is a Spanish biotechnology company focused on developing a new class of antimicrobial therapies to combat difficult-to-treat infections, particularly hospital-acquired bacterial pneumonia (HABP) and ventilator-associated bacterial pneumonia (VABP). Their lead program targets Acinetobacter baumannii, a multidrug-resistant pathogen. The company's proprietary APEX platform is designed to create biologically derived, protein-based therapeutics that aim to overcome the limitations…
What is Telum Therapeutics's revenue?
StartupHub estimates Telum Therapeutics's annual revenue at $2.1M (range $694K to $11.7M, 33% confidence), based on comparable companies in the sector.
What is Telum Therapeutics's valuation?
StartupHub estimates Telum Therapeutics's effective valuation at $80.6M (range $52.5M to $126.0M, 24% confidence), based on comparable companies in the sector.
How much funding has Telum Therapeutics raised?
Telum Therapeutics has raised a total of $21M in funding. The most recent round on record is Series A.
Where is Telum Therapeutics headquartered?
Telum Therapeutics is headquartered in Navarra, Spain.
When was Telum Therapeutics founded?
Telum Therapeutics was founded in 2019.
What industry does Telum Therapeutics operate in?
Telum Therapeutics operates in Biotechnology, Pharmaceuticals, Drug Discovery, Antimicrobial Resistance, Biotech, Antimicrobial Therapeutics.
Galatek develops AI-driven automation solutions for life sciences laboratories and advanced semiconductor manufacturing, focusing on precision and reproducibility.
Digital batch record software for pharmaceutical and biotech manufacturing.
Develops and commercializes treatments for central nervous system disorders, including Rett syndrome.
A deep-tech company developing nanorobotic solutions for healthcare, initially targeting dental care applications.
MatrixCode is a research focus at the Freiburg Institute for Advanced Studies (FRIAS) investigating matrisome pathology.
A company focused on privacy, Zcash accumulation, and developing cancer therapeutics.
An entrant is a company tagged Biotechnology whose domain was first registered in the window, counted from registry records in the StartupHub directory. Registry detection runs two to three weeks behind registration, so recent weeks are a floor.
No comments yet. Be the first to share your take.